| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8515700 | Medical Hypotheses | 2018 | 22 Pages |
Abstract
Fibrinogen and ESR cannot be used for monitoring the CPAP therapy in patients with OSAS and arrhythmias. Instead, the beneficial effect of CPAP in patients with OSAS and cardiac arrhythmias can be monitored with the help of the RDW, which could also be used for evaluating the cardiovascular risk in patients with OSAS and arrhythmias.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Developmental Biology
Authors
G.N. Dediu, C.C. Diaconu, S. Dumitrache Rujinski, M.A. Iancu, L.A. Balaceanu, I. Dina, M. Bogdan,